Effect of FIXed-dose combination of ARb and statin on adherence and risk factor control: The randomized FIXAR study

Abstract

Patients' adherence was excellent and similar in the groups, whereas the reduction in the LDL-C level was greater in the FDC group. We provide comprehensive information on the adherence and efficacy of an FDC compared to the usual regimen in Korean patients with high cardiovascular risk.